Bio-Rad Laboratories (BIO) Non Operating Investment Income (2018 - 2026)

Bio-Rad Laboratories (BIO) has 9 years of Non Operating Investment Income data on file, last reported at -$738.2 million in Q1 2026.

• On a quarterly basis, Non Operating Investment Income fell 2421.38% year-over-year to -$738.2 million in Q1 2026; TTM through Mar 2026 was -$867.3 million, a 47.39% increase from a year earlier, with the FY2020 full-year figure at $4.5 billion, up 121.36% from the prior year.
• Non Operating Investment Income for Q1 2026 stood at -$738.2 million, down from -$495.3 million in the prior quarter.
• Over the last five years, Non Operating Investment Income for BIO reached as high as $792.9 million in Q3 2024 and fell as low as -$4.5 billion in Q1 2022.
• Historically, Non Operating Investment Income has averaged -$792.0 million across 5 years, with a median of -$289.0 million in 2022.
• Across the five-year window, Non Operating Investment Income jumped 2509.13% in 2024 and plunged 2421.38% in 2026, its largest moves.
• Year by year, Non Operating Investment Income stood at -$289.0 million in 2022, then surged by 112.6% to $36.4 million in 2023, then jumped by 2076.8% to $792.9 million in 2024, then slumped by 162.47% to -$495.3 million in 2025, then slumped by 49.04% to -$738.2 million in 2026.
• Per Business Quant data, the three most recent Non Operating Investment Income figures were -$738.2 million in Q1 2026, -$495.3 million in Q3 2025, and $334.4 million in Q2 2025.